<?xml version="1.0" encoding="UTF-8"?>
<document id="DDI-DrugBank.d427">
    <sentence id="DDI-DrugBank.d427.s0" text="Elevated plasma levels of theophylline have been reported with concomitant quinolone use.">
        <entity id="DDI-DrugBank.d427.s0.e0" charOffset="26-37"
            type="drug" text="theophylline"/>
        <entity id="DDI-DrugBank.d427.s0.e1" charOffset="75-83"
            type="group" text="quinolone"/>
        <pair id="DDI-DrugBank.d427.s0.p0" e1="DDI-DrugBank.d427.s0.e0"
            e2="DDI-DrugBank.d427.s0.e1" ddi="true" type="mechanism"/>
    </sentence>
    <sentence id="DDI-DrugBank.d427.s1" text="There have been reports of theophylline-related side effects in patients on concomitant therapy with quinolones and theophylline.">
        <entity id="DDI-DrugBank.d427.s1.e0" charOffset="27-38"
            type="drug" text="theophylline"/>
        <entity id="DDI-DrugBank.d427.s1.e1" charOffset="101-110"
            type="group" text="quinolones"/>
        <entity id="DDI-DrugBank.d427.s1.e2" charOffset="116-127"
            type="drug" text="theophylline"/>
        <pair id="DDI-DrugBank.d427.s1.p0" e1="DDI-DrugBank.d427.s1.e0"
            e2="DDI-DrugBank.d427.s1.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d427.s1.p1" e1="DDI-DrugBank.d427.s1.e0"
            e2="DDI-DrugBank.d427.s1.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d427.s1.p2" e1="DDI-DrugBank.d427.s1.e1"
            e2="DDI-DrugBank.d427.s1.e2" ddi="true" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d427.s2" text="Therefore, monitoring of theophylline plasma levels should be considered and dosage of theophylline adjusted, as required.">
        <entity id="DDI-DrugBank.d427.s2.e0" charOffset="25-36"
            type="drug" text="theophylline"/>
        <entity id="DDI-DrugBank.d427.s2.e1" charOffset="87-98"
            type="drug" text="theophylline"/>
        <pair id="DDI-DrugBank.d427.s2.p0" e1="DDI-DrugBank.d427.s2.e0"
            e2="DDI-DrugBank.d427.s2.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d427.s3" text="Quinolones have been shown to interfere with the metabolism of caffeine.">
        <entity id="DDI-DrugBank.d427.s3.e0" charOffset="0-9"
            type="group" text="Quinolones"/>
        <entity id="DDI-DrugBank.d427.s3.e1" charOffset="63-70"
            type="drug" text="caffeine"/>
        <pair id="DDI-DrugBank.d427.s3.p0" e1="DDI-DrugBank.d427.s3.e0"
            e2="DDI-DrugBank.d427.s3.e1" ddi="true" type="mechanism"/>
    </sentence>
    <sentence id="DDI-DrugBank.d427.s4" text="This may lead to reduced clearance of caffeine and the prolongation of its plasma half-life.">
        <entity id="DDI-DrugBank.d427.s4.e0" charOffset="38-45"
            type="drug" text="caffeine"/>
    </sentence>
    <sentence id="DDI-DrugBank.d427.s5" text="Quinolones, including nalidixic acid, may enhance the effects of the oral anticoagulant warfarin or its derivatives.">
        <entity id="DDI-DrugBank.d427.s5.e0" charOffset="0-9"
            type="group" text="Quinolones"/>
        <entity id="DDI-DrugBank.d427.s5.e1" charOffset="22-35"
            type="drug" text="nalidixic acid"/>
        <entity id="DDI-DrugBank.d427.s5.e2" charOffset="74-86"
            type="group" text="anticoagulant"/>
        <entity id="DDI-DrugBank.d427.s5.e3" charOffset="88-95"
            type="drug" text="warfarin"/>
        <pair id="DDI-DrugBank.d427.s5.p0" e1="DDI-DrugBank.d427.s5.e0"
            e2="DDI-DrugBank.d427.s5.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d427.s5.p1" e1="DDI-DrugBank.d427.s5.e0"
            e2="DDI-DrugBank.d427.s5.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d427.s5.p2" e1="DDI-DrugBank.d427.s5.e0"
            e2="DDI-DrugBank.d427.s5.e3" ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d427.s5.p3" e1="DDI-DrugBank.d427.s5.e1"
            e2="DDI-DrugBank.d427.s5.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d427.s5.p4" e1="DDI-DrugBank.d427.s5.e1"
            e2="DDI-DrugBank.d427.s5.e3" ddi="true" type="effect"/>
        <pair id="DDI-DrugBank.d427.s5.p5" e1="DDI-DrugBank.d427.s5.e2"
            e2="DDI-DrugBank.d427.s5.e3" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d427.s6" text="When these products are administered concomitantly, prothrombin time or other suitable coagulation test should be closely monitored."/>
    <sentence id="DDI-DrugBank.d427.s7" text="Nitrofurantoin interferes with the therapeutic action of nalidixic acid.">
        <entity id="DDI-DrugBank.d427.s7.e0" charOffset="0-13"
            type="drug" text="Nitrofurantoin"/>
        <entity id="DDI-DrugBank.d427.s7.e1" charOffset="57-70"
            type="drug" text="nalidixic acid"/>
        <pair id="DDI-DrugBank.d427.s7.p0" e1="DDI-DrugBank.d427.s7.e0"
            e2="DDI-DrugBank.d427.s7.e1" ddi="true" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d427.s8" text="Antacids containing magnesium, aluminum, or calcium;">
        <entity id="DDI-DrugBank.d427.s8.e0" charOffset="0-7"
            type="group" text="Antacids"/>
        <entity id="DDI-DrugBank.d427.s8.e1" charOffset="20-28"
            type="drug" text="magnesium"/>
        <entity id="DDI-DrugBank.d427.s8.e2" charOffset="31-38"
            type="drug" text="aluminum"/>
        <entity id="DDI-DrugBank.d427.s8.e3" charOffset="44-50"
            type="drug" text="calcium"/>
        <pair id="DDI-DrugBank.d427.s8.p0" e1="DDI-DrugBank.d427.s8.e0"
            e2="DDI-DrugBank.d427.s8.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d427.s8.p1" e1="DDI-DrugBank.d427.s8.e0"
            e2="DDI-DrugBank.d427.s8.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d427.s8.p2" e1="DDI-DrugBank.d427.s8.e0"
            e2="DDI-DrugBank.d427.s8.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d427.s8.p3" e1="DDI-DrugBank.d427.s8.e1"
            e2="DDI-DrugBank.d427.s8.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d427.s8.p4" e1="DDI-DrugBank.d427.s8.e1"
            e2="DDI-DrugBank.d427.s8.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d427.s8.p5" e1="DDI-DrugBank.d427.s8.e2"
            e2="DDI-DrugBank.d427.s8.e3" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d427.s9" text="sucralfate or divalent or trivalent cations such as iron;">
        <entity id="DDI-DrugBank.d427.s9.e0" charOffset="0-9"
            type="drug" text="sucralfate"/>
        <entity id="DDI-DrugBank.d427.s9.e1" charOffset="52-55"
            type="drug" text="iron"/>
        <pair id="DDI-DrugBank.d427.s9.p0" e1="DDI-DrugBank.d427.s9.e0"
            e2="DDI-DrugBank.d427.s9.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d427.s10" text="multivitamins containing zinc;">
        <entity id="DDI-DrugBank.d427.s10.e0" charOffset="0-12"
            type="group" text="multivitamins"/>
        <entity id="DDI-DrugBank.d427.s10.e1" charOffset="25-28"
            type="drug" text="zinc"/>
        <pair id="DDI-DrugBank.d427.s10.p0"
            e1="DDI-DrugBank.d427.s10.e0" e2="DDI-DrugBank.d427.s10.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d427.s11" text="and Videx , (Didanosine), chewable/buffered tablets or the pediatric powder for oral solution may substantially interfere with the absorption of quinolones, resulting in systemic levels considerably lower than desired.">
        <entity id="DDI-DrugBank.d427.s11.e0" charOffset="4-8"
            type="brand" text="Videx"/>
        <entity id="DDI-DrugBank.d427.s11.e1" charOffset="13-22"
            type="drug" text="Didanosine"/>
        <entity id="DDI-DrugBank.d427.s11.e2" charOffset="145-154"
            type="group" text="quinolones"/>
        <pair id="DDI-DrugBank.d427.s11.p0"
            e1="DDI-DrugBank.d427.s11.e0" e2="DDI-DrugBank.d427.s11.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d427.s11.p1"
            e1="DDI-DrugBank.d427.s11.e0" e2="DDI-DrugBank.d427.s11.e2"
            ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d427.s11.p2"
            e1="DDI-DrugBank.d427.s11.e1" e2="DDI-DrugBank.d427.s11.e2"
            ddi="true" type="mechanism"/>
    </sentence>
    <sentence id="DDI-DrugBank.d427.s12" text="These agents should not be taken within the two hour period before or within the two-hour period after nalidixic acid administration.">
        <entity id="DDI-DrugBank.d427.s12.e0" charOffset="103-116"
            type="drug" text="nalidixic acid"/>
    </sentence>
    <sentence id="DDI-DrugBank.d427.s13" text="Elevated serum levels of cyclosporine have been reported with the concomitant use of some quinolones and cyclosporine.">
        <entity id="DDI-DrugBank.d427.s13.e0" charOffset="25-36"
            type="drug" text="cyclosporine"/>
        <entity id="DDI-DrugBank.d427.s13.e1" charOffset="90-99"
            type="group" text="quinolones"/>
        <entity id="DDI-DrugBank.d427.s13.e2" charOffset="105-116"
            type="drug" text="cyclosporine"/>
        <pair id="DDI-DrugBank.d427.s13.p0"
            e1="DDI-DrugBank.d427.s13.e0" e2="DDI-DrugBank.d427.s13.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d427.s13.p1"
            e1="DDI-DrugBank.d427.s13.e0" e2="DDI-DrugBank.d427.s13.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d427.s13.p2"
            e1="DDI-DrugBank.d427.s13.e1" e2="DDI-DrugBank.d427.s13.e2"
            ddi="true" type="mechanism"/>
    </sentence>
    <sentence id="DDI-DrugBank.d427.s14" text="Therefore, cyclosporine serum levels should be monitored and appropriate cyclosporine dosage adjustments made when these drugs are used concomitantly.">
        <entity id="DDI-DrugBank.d427.s14.e0" charOffset="11-22"
            type="drug" text="cyclosporine"/>
        <entity id="DDI-DrugBank.d427.s14.e1" charOffset="73-84"
            type="drug" text="cyclosporine"/>
        <pair id="DDI-DrugBank.d427.s14.p0"
            e1="DDI-DrugBank.d427.s14.e0" e2="DDI-DrugBank.d427.s14.e1" ddi="false"/>
    </sentence>
</document>
